Literature DB >> 23836405

Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.

Wei Gong1, Zhi-Yong Wang, Guo-Xi Chen, Yu-Qiao Liu, Xiao-Yan Gu, Wen-Wei Liu.   

Abstract

The functional relationship and cross-regulation between damage-associated molecular patterns and NF‑κB in the tumor microenvironment remains unclear. In the present study, high-mobility group protein B1 (HMGB1) was secreted in response to feed second phase of NF‑κB activation from heat shock protein (HSP) 70 that may result in a higher invasion potential of hepatocarcinoma cells. HSP70 promoted the proliferation of H22 hepatocarcinoma cells through Toll-like receptor (TLR) 2 and TLR4 signaling and induced the early phosphorylation of NF-κB, which reached maximum levels within 30 min. However, HSP70 promoted the upregulation of Beclin-1 expression via Jun N-terminal kinase (JNK) activation in tumor cells and the release of HMGB1 from tumor cells. Inhibition of Beclin-1/c-JNK production prevented the second, but not the first, phase of NF-κB phosphorylation, implicating Beclin-1/c-JNK in the second phase of phosphorylation. HSP70 induced Beclin-1-derived HMGB1 production at 4 h, which occurred before the rise in the second phosphorylation that occurred at 6 h. Exogenous HMGB1 also induced the rapid phosphorylation of NF-κB and upregulated the expression of MMP-9, inhibited the rapid phosphorylation of NF-κB and reduced MMP-9 by receptor for advanced glycation end products (RAGE) inhibitor that prevented HMGB1-induced cell invasion in vitro, which demonstrated that the biological significance of HMGB1/RAGE is key to the second, but not the first, phase of NF-κB phosphorylation in tumor cells. HSP70 triggered a positive feedback loop of NF-κB activation in H22 cells. The second phase of NF-κB phosphorylation mediated by HSP70 is implicated in the increase of tumor cell malignant invasion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836405     DOI: 10.3892/or.2013.2595

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

2.  Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.

Authors:  Yi Zhe; Yan Li; Dan Liu; Dong-Ming Su; Jin-Gang Liu; Hang-Yu Li
Journal:  Tumour Biol       Date:  2016-08-04

Review 3.  Inflammatory signaling cascades and autophagy in cancer.

Authors:  Teresa Monkkonen; Jayanta Debnath
Journal:  Autophagy       Date:  2017-09-18       Impact factor: 16.016

Review 4.  Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?

Authors:  Jorge André Gomes Lopes; Marta Borges-Canha; Pedro Pimentel-Nunes
Journal:  World J Hepatol       Date:  2016-01-28

5.  Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4-dependent manner.

Authors:  Xinxu Min; Xiaofei Cao; Hao Cheng; Ziyang Chen; Xiaojin Zhang; Yunfan Li; Qian Mao; Bin Xue; Lei Fang; Li Liu; Zhengnian Ding
Journal:  Cell Stress Chaperones       Date:  2022-01-20       Impact factor: 3.827

6.  Hydrostatic pressure influences HIF-2 alpha expression in chondrocytes.

Authors:  Hiroaki Inoue; Yuji Arai; Tsunao Kishida; Ryu Terauchi; Kuniaki Honjo; Shuji Nakagawa; Shinji Tsuchida; Tomohiro Matsuki; Keiichirou Ueshima; Hiroyoshi Fujiwara; Osam Mazda; Toshikazu Kubo
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923

Review 7.  Role of receptor for advanced glycation end products (RAGE) in liver disease.

Authors:  Sho-ichi Yamagishi; Takanori Matsui
Journal:  Eur J Med Res       Date:  2015-02-11       Impact factor: 2.175

8.  The complex function of hsp70 in metastatic cancer.

Authors:  Kata Juhasz; Anna-Maria Lipp; Benedikt Nimmervoll; Alois Sonnleitner; Jan Hesse; Thomas Haselgruebler; Zsolt Balogi
Journal:  Cancers (Basel)       Date:  2013-12-20       Impact factor: 6.639

9.  HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.

Authors:  Yanmei Chen; Chengzhao Lin; Yang Liu; Yan Jiang
Journal:  Tumour Biol       Date:  2015-10-24

Review 10.  Emerging role of Toll-like receptor 4 in hepatocellular carcinoma.

Authors:  Jing Yang; Min Li; Qi Chang Zheng
Journal:  J Hepatocell Carcinoma       Date:  2015-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.